Remove Doctors Remove FDA Approval Remove Research Laboratories
article thumbnail

FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction

The Pharma Data

FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction. The approval of Verquvo provides doctors, health care professionals, and patients with a welcome new option to current available therapies.”. Related Articles: Verquvo (vericiguat) FDA Approval History. KENILWORTH, N.J.–(BUSINESS

article thumbnail

VERQUVO® (vericiguat) Approved in the European Union

The Pharma Data

Bayer also issued a news release earlier today announcing the EC approval. Food and Drug Administration (FDA) approved VERQUVO in the U.S. The approval of VERQUVO in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Data Show Treatment with Lilly’s Neutralizing Antibodies Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) Together Reduced Risk of COVID-19 Hospitalizations and Death by 70 Percent

The Pharma Data

Lilly’s chief scientific officer and president of Lilly Research Laboratories. In November, Lilly submitted a request to the FDA for emergency use authorization (EUA) for bamlanivimab and etesevimab together as another treatment for mild to moderate COVID-19 in high-risk patients. It remains under review by the FDA.

article thumbnail

Q&A: How a partnership between physicians and researchers aims to make cancer drugs safer

Broad Institute

Kerry Reynolds: The first immune checkpoint inhibitor was FDA-approved in 2011 to treat melanoma, with nearly a dozen more ICIs approved for various cancers since then. The longer patients wait to inform their doctor, the more complex it can become. How big of a problem are these complications from cancer immunotherapy?

Research 131
article thumbnail

The Quest for Universal Flu Vaccines

Codon

Jonas Salk in his Virus Research Laboratory (1954), together with assistant J.S. There is only one FDA-approved intranasal vaccine for any disease: the FluMist Quadrivalent flu vaccine, which uses weakened forms of viruses to trigger an immune response. “Antigenic shift,” though, poses an even greater threat.

Vaccine 116
article thumbnail

The Origins of Adjuvants

Codon

Either way, young James set out for the doctor’s home to receive the world’s first vaccine. The Alum Age Tapioca never featured in any human vaccines, though, because just one year after Ramon’s discovery, other researchers serendipitously discovered a superior adjuvant.